Longevitix Expands Clinical Platform for Women's Health

The clinical intelligence platform now examines seven women's health domains and connects with major wearable devices.

Updated on Nov. 11, 2026 in Women’s Health

Quiet office scene with a ceramic cup and silver wearable ring on a pale oak desk beside a sheer window, soft daylight.
Longevitix expanded its clinical intelligence platform on Tuesday to cover seven women's health domains and connect with Oura, Apple Health, and Whoop devices. AI Illustration. Upload story photo >

Longevitix announced an extension of its clinical intelligence platform dedicated to women's health. The platform examines health across more than 15 clinical domains, seven of which focus on women's health.

Why it matters

The company states that patient information often remains fragmented across providers and devices. The platform aims to bring that data into one clinical view that physicians can use for prevention and personalized care.

The company reports that the platform covers more than 15 clinical domains, with seven dedicated to women's health. No independent clinical validation or adoption metrics were included, and the figures reflect company-reported scope.

The players

Longevitix

Longevitix is a health technology company that develops a clinical intelligence platform, founded in early 2025.

Dr. Neil Panchal

Dr. Neil Panchal is a co-founder of Longevitix and serves as its chief medical officer.

The details

The platform interprets clinical findings according to a woman's life stage and combines medical records, laboratory results, imaging, wearable data, medical history, and patient-reported symptoms. Patients can record symptoms in daily journals, and the platform connects with Oura, Apple Health, and Whoop devices.

Timeline

  1. 2025: Longevitix was founded by Effie Arditi, Gaby Hayon, and Dr. Neil Panchal.

  2. November 11, 2026: Longevitix announced the extension of its women's health platform.

Women's Health Landscape

The platform extends the consumer wearable trend by pulling data from Apple Health and Oura into a clinician-facing view rather than leaving it in consumer apps. Its seven women's health domains, including hormones, cancer screening, and bone health, target areas that fragmented care has historically handled separately.

Patients whose records and wearable data are spread across providers could see that information combined for their physicians. Physicians may be able to weigh lifestyle, supplement, and hormone therapy options in one place, though the source does not describe changes to coverage or cost.

The takeaway

Patients tracking symptoms and wearable data can ask their physicians whether their clinical records are being connected. Keeping a daily symptom journal may help make those conversations more specific.

Further reading

Explore more coverage in the Women's Health section.

More information

More information about the platform is available on the Longevitix company website.

Source note: This article includes information reported by The Manila times.